Related Experiment Video
Updated: Aug 2, 2026

Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking
Published on: August 6, 2013
Treating tobacco use and dependence in clinical practice
1Department of Ambulatory Care and Community Medicine, University Hospital, CH-1011 Lausanne, Switzerland. Jacques.Cornuz@chuv.ch
Physicians can help smokers quit by tailoring strategies to their readiness to quit. Pharmacotherapies like nicotine replacement therapy and bupropion effectively double cessation rates when combined with behavioral support.
Area of Science:
- Medical Science
- Public Health
- Addiction Medicine
Background:
- Physicians play a crucial role in addressing nicotine dependence.
- Smoking cessation interventions require tailored strategies based on patient motivation.
- Primary care settings are ideal for implementing smoking cessation programs.
Purpose of the Study:
- To review intervention strategies for smoking cessation in primary care.
- To outline physician-led approaches based on patient readiness to quit.
- To highlight the role of pharmacotherapy and behavioral support in smoking cessation.
Main Methods:
- Literature review of smoking cessation strategies in primary care.
- Categorization of interventions based on patient's stage of change (precontemplation, contemplation, preparation).
- Analysis of pharmacotherapeutic options and behavioral counseling techniques.
Main Results:
- For smokers unwilling to quit, education on tobacco risks and cessation benefits is recommended.
- For ambivalent smokers, motivational interviewing addressing barriers and solutions is effective.
- For smokers ready to quit, comprehensive support including setting a quit date, pharmacotherapy (nicotine replacement therapy, bupropion), and relapse prevention strategies are crucial.
- Pharmacotherapies roughly double smoking cessation rates compared to no intervention.
Conclusions:
- Physician-guided smoking cessation interventions are effective when tailored to patient readiness.
- A combination of pharmacotherapy and behavioral support significantly enhances quit rates.
- Primary care physicians are pivotal in managing nicotine dependence and promoting tobacco cessation.
Related Concept Videos
Drug Dependence
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
CNS Depressants: Alcohol and Nicotine
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...

